Previous 10 | Next 10 |
Gainers: Rubicon Technology ( RBCN ) +68% . Faraday Future Intelligent Electric ( FFIE ) +65% . Ra Medical Systems ( RMED ) +61% . Xilio Therapeutics ( XLO ) +35% . Maris-Tech ( MTEK ) +35% . Lexicon Pharmaceuticals ( LXRX ...
Avadel Pharmaceuticals ( NASDAQ: AVDL ) is trading 18% higher after the company said it expects to receive tentative approval from the U.S. FDA of its therapy FT218 to treat narcolepsy. The company said it was exploring every available pathway to accelerate th...
Pursuing strategies to accelerate final approval of FT218 NDA Optimizing cost structure to fund strategic priorities and extend cash runway Continuing key activities to accelerate launch timing of FT218, targeting multi-billion-dollar narcolepsy market opportunit...
AVDL's FT218 is going to get delayed further over a patent issue. However, there's a goalpost in sight now, and the date is June 2023. The company is cash-strapped. For further details see: Avadel: Further Delay, But Some Light At The End Of The Tunnel
UBS has launched its coverage on Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Buy rating and a $194 per share target, arguing that investors have underestimated the growth prospects of Ireland-based pharma’s cannabidiol drug, Epidiolex. Jazz (JAZZ) recorded ~6% growth of Epidiolex net pro...
Jazz Pharmaceuticals missed first quarter revenue estimates, but management raised the full-year guidance. The launch of Xywav in idiopathic hypersomnia looks strong, and has driven the best quarter for the oxybate franchise since mid-2020. Business development activity picked up ...
JOANN (JOAN) -17% on Q1 earnings release. Boqii Holding (BQ) -10%. Asana (ASAN) -9% on Q1 earnings release. Avadel Pharmaceuticals (AVDL) -6% is collaborating with the American Academy of Sleep Medicine Foundation, to support its 2022 Young Investigators Research...
DUBLIN, Ireland, June 03, 2022 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it entered into an exclusive collaboration with the American Academy of Sleep Medicine (AASM) ...
Avadel Pharmaceuticals (NASDAQ:AVDL) reported 10K shares acquired by Director Palczuk Linda for $1.6/share while Director Ende Eric J purchased 15K shares for $2.45/share. Director Thornton Peter J. purchased 50K shares for $1.69/share. CEO Divis Gregory J and CFO Mchugh Thomas S. acquir...
3 Tips for Making Money With Penny Stocks Next Month If you’re thinking about buying and selling penny stocks in June, you need to know what you’re doing. There are a lot of things that can go wrong, and if you’re not careful, you could end up losing a lot of money....
News, Short Squeeze, Breakout and More Instantly...
Avadel Pharmaceuticals plc Company Name:
AVDL Stock Symbol:
NASDAQ Market:
Avadel Pharmaceuticals plc Website:
DUBLIN, June 27, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it is set to join the broad-market Russell 3000 ® Index at the conclusion of the 2024 Russell US Ind...
2024-05-29 06:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
– 11 accepted abstracts, including new data reiterating satisfaction, preference and clinical benefit of LUMRYZ – – Presentations highlight Avadel’s continued commitment to address gaps in narcolepsy care – DUBLIN, May 22, 2024 (GLOBE NEWSWIRE) -...